Search Login Register
Cimetidine
(Biomet)
Summary
Description:
A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRINS output. It also blocks the activity of CYTOCHROME P-450 which might explain proposals for use in NEOADJUVANT THERAPY.
Also Known As:
Biomet; Tagamet; Altramet; Biomet400; Cimetidine HCl Show All >>
Networked: 3557
relevant articles (361 outcomes,
646 trials/studies)
for this Drug
Key Diseases for which Cimetidine is
Relevant
-
Duodenal Ulcer (Curling's Ulcer)
:
78 outcomes 197 studies in 721 results
-
Ulcer
:
62 outcomes 100 studies in 647 results
-
Stomach Ulcer (Gastric Ulcer)
:
37 outcomes 74 studies in 276 results
-
Hemorrhage
:
32 outcomes 48 studies in 217 results
-
Peptic Ulcer (Peptic Ulcers)
:
30 outcomes 46 studies in 293 results
Show All >>
Drugs Related to Cimetidine
-
Ranitidine (Zantac)
-
Sucralfate (Carafate)
-
Histamine (Histamine Dihydrochloride)
-
Pirenzepine
-
Omeprazole (Esomeprazole)
-
Famotidine (Pepcid)
-
Antacids
-
Misoprostol (Cytotec)
-
Diphenhydramine (Benadryl)
-
bismuth tripotassium dicitrate (bismuth subcitrate)
Show All >>
Therapies Related to Cimetidine
-
Drug Therapy (Chemotherapy)
-
Aftercare (After-Treatment)
-
Premedication
-
Prostheses and Implants (Prosthesis)
-
Cesarean Section (Caesarean Section)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.